Shahram Salek-Ardakani
Plus aucun poste en cours
Profil
Shahram Salek-Ardakani held the position of Senior Director-Cancer Immunology at Pfizer Inc. He also worked as an Associate Professor at the University of Florida College of Medicine.
Currently, he is serving as the Chief Scientific Officer at Janux Therapeutics, Inc. from 2021 to 2023.
Anciens postes connus de Shahram Salek-Ardakani
| Sociétés | Poste | Fin |
|---|---|---|
| JANUX THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/11/2023 |
| University of Florida College of Medicine | Corporate Officer/Principal | - |
| PFIZER, INC. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
8
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| JANUX THERAPEUTICS, INC. | Health Technology |
